Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
BPC-157 + TB-500 Peptide Blend (10mg) Research Grade Lyophilized Powder
Opioid receptors
CD38 Inhibits Prostate oncology research models Metabolism and Proliferation by [PMID: 30076241] Laboratory literature summary: CD38 Inhibits Prostate oncology research models Metabolism and Proliferation by Reducing Cellular NAD(+) Pools
TB-500 acts systemically, mobilizing stem cells, suppressing inflammatory cytokines, and regulating actin for tissue remodeling
In the 26-week phase 2 trial, mean weight reduction across the 0.34.5 mg arms was 6.010.8% versus 3.0% for placebo
US$ 27.39
US$ 26.06
US$ 25.01
US$ 23.90
US$ 20.02
US$ 22.04
